Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
George Anton, MD, is Chief of Vascular Surgery in the Department of Vascular Surgery at Hillcrest Hospital, a Cleveland Clinic hospital. Dr. Anton was appointed to Cleveland Clinic in 1999. He served as a Clinical Associate in the Vascular Surgery Department after completing a fellowship at Cleveland Clinic.
Dr. Anton’s specialty interests include carotid artery surgery, thoracic-abdominal aortic repair and reconstruction, thoracic aortic aneurysm repair, abdominal aortic aneurysm repair, sclerotherapy, and peripheral artery and vein repair and bypass surgery.
He attended Long Island College, graduating magna cum laude and received his medical degree from Howard University College of Medicine, Washington, D.C. Dr. Anton completed his postdoctoral education, including an internship and residency in surgery, followed by a fellowship in vascular surgery, all at Cleveland Clinic. He is board-certified by the American Board of Surgery in surgery and the subspecialty of general vascular surgery.
Dr. Anton has written articles for scientific journals and spoken at medical conferences. He was named to "The Best Doctors in America-Midwest Region" in 1996. He is a member of the Cleveland and Midwestern Vascular Surgical Societies and the Ohio State Medical Association Peripheral Vascular Surgical Society.
Vascular surgery, varicose veins, venous disorders, sclerotherapy, medical management of PAD, non-invasive testing for vascular disease, repair of venous aneurysms, vein ablation, vascular tests
Awards & Honors
The Best Doctors in America, Midwest Region, 1996-1997
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/2/2013, Dr. Anton has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.